The Robert H. Lurie Comprehensive Cancer Center of Northwestern University is expanding its partnership with Tempus aimed at personalizing care for cancer patients. Tempus provides molecular sequencing and clinical analytic solutions for top academic centers, hospital systems, associations, and healthcare providers.As part of the expanded collaboration, Tempus will provide molecular sequencing and analysis for patient derived xenograft (PDX) models and patient derived organoid models, which will
Read More
Cancer Genomics
Penn Medicine’s Abramson Cancer Center Launches Initiative to Improve & Personalize BRCA Mutations
Cancer experts at the Basser Center for BRCA in the Abramson Cancer Center of the University of Pennsylvania have announced a new collaboration with Tempus to improve and personalize treatment for patients with heritable BRCA mutations. Tempus, a technology company focused on helping doctors personalize cancer treatment will analyze the molecular and clinical data of patients who were treated at the Basser Center and harbor a BRCA mutation using machine learning and advanced
Read More
IBM Watson, Illumina Partner to Simplify Genomic Data Interpretation
IBM Watson Health and Illumina are teaming up to standardize and simplify genomic data interpretation by integrating Watson for Genomics into Illumina's BaseSpace Sequence Hub and tumor sequencing process. Genome sequencing has increased in recent years following two decades of research demonstrating the promise of precision medicine. However, access to these advances has been limited by the significant time and expense required to interpret the genomic data.By integrating Watson for Genomics
Read More
Genos Unveils Crowdsourcing Platform for Genomics R&D
Genos, a community for personal genetic discovery and research has announced the public launch of its crowdsourcing platform for genomics research and development. The Genos platform will enable individuals to sequence their genetic profiles with 50 times more data than current popular sequencing options, while empowering individuals to participate in groundbreaking research projects on their own terms. As part of the platform launch, Genos revealed several initial research partners and
Read More
Philips, N-of-One Partner to Speed Clinical Interpretation of Cancer Genomics
Royal Philips and N-of-One, Inc., a provider of clinical interpretation of molecular tests in oncology is teaming up to enhance the capabilities of Philips’ IntelliSpace Genomics solution. The two companies will collaborate on the clinical analysis, annotation and interpretation of oncology cases processed through Philips’ new precision medicine solution for oncology.This healthcare informatics solution integrates genomic information with full patient context to empower clinicians with
Read More
Westchester Medical Launches Precision Medicine Initiative for Personalized Cancer Treatment
Westchester Medical Center Health Network (WMCHealth), a provider of advanced medical care in New York’s Hudson Valley is teaming up with Philips to launch a new precision medicine initiative for personalized cancer treatment. As part of the precision medicine initiative, WMCHealth will use Philips’ IntelliSpace Genomics solution to integrate large-scale genomic analysis with extensive patient clinical data, to provide a comprehensive patient view for precision-tailored treatment. With base
Read More
IBM Watson, Quest Diagnostics Partner to Offer Gene Sequencing Service
IBM Watson is teaming up with Quest Diagnostics to launch Watson Genomics from Quest Diagnostics, a gene sequencing and Watson diagnostic analysis service to help oncologists deliver precision medicine to their patients. Together with Memorial Sloan Kettering Cancer Center (MSK), the service will provide a personalized tumor analysis of a patient’s sequenced genomic tumor that is supported by clinical evidence. As part of the precision medicine partnership, The Broad Institute of MIT and Harvard
Read More
IBM Watson, NY Genome Center to Create Open Cancer Data Repository
Unveiled during Thursdays's White House Precision Medicine Initiative Summit, the New York Genome Center and IBM Watson are teaming up to create a comprehensive and open repository of genetic data to accelerate cancer research and scale access to precision medicine. Utilizing cognitive insights from IBM Watson, the partnership could help transform the way physicians deliver personalized treatment to individual patients.
Open Cancer Data Repository Details
Together, IBM and New York Genome
Read More
Google Partners to Create Cancer Genomics Cloud Platform
The Research at Google team is partnering with the Institute for Systems Biology (ISB) and SRA International, Inc to develop a Cancer Genomics Cloud (CGC). The platform will serve as a large-scale data repository and provide the computational infrastructure necessary to carry out cancer genomics research at unprecedented scales.
The $6.5M two-year project funded by the NIH’s National Cancer Institute (NCI) will migrate data collected from the TCGA (The Cancer Genome Atlas) to Google Cloud
Read More
